Results 21 to 30 of about 149,498 (247)

Geographic Variations and Time Trends in Cancer Treatments in Taiwan

BMC Public Health, 2017
Background Targeted therapies have become important treatment options for cancer care in many countries. This study aimed to examine recent trends in utilization of antineoplastic drugs, particularly the use of targeted therapies for treatment of cancer,
Jason C. Hsu, Sheng-Mao Chang, Christine Y. Lu   +2 more
doaj   +1 more source

Ocular complications of antineoplastic therapies

Future Science OA, 2023
Ocular complications of antineoplastic agents can have a profound effect on the quality of life of cancer patients. New oncologic treatments like monoclonal antibodies, immunotherapies, antibody-drug conjugates, checkpoint inhibitors and growth factor ...
Abbas Bader, Madeline Begemann, Ammar Al-Obaidi, Muhammad Hamza Habib, Faiz Anwer, Shahzad Raza   +5 more
doaj   +1 more source

Strategic Improvement of Oral Antineoplastic Investigational Agents Compliance [PDF]

Global Journal on Quality and Safety in Healthcare, 2019
Background: The use of oral antineoplastic agents has increased in cancer medicine. However, the convenience of oral medication carries the risk of nonadherence and dosing errors, which could jeopardize therapeutic benefits and patient safety.
Anas Alshawa, Jing Gong, Valerie Marcott, Rabia Khan, Valentine Boving, Lakeshia Brown, Jeff Beno, Ed Kheder, Siqing Fu   +8 more
doaj   +1 more source

O-39 CLINICAL CHARACTERISTICS AND OUTCOME OF DRUG-INDUCED LIVER INJURY DUE TO ANTINEOPLASTIC AND BIOLOGICAL AGENTS

Annals of Hepatology, 2023
Introduction and Objectives: Idiosyncratic drug-induced liver injury (DILI) caused by antineoplastic and biological agents is an emerging clinical burden in oncologic patients.
Fernando Bessone, Nelia Hernandez, Raymundo Parana, Maria Isabel Schinoni, Manuel Mendizabal, Adriana Sanchez, Vinicius Nunes, Ezequiel Ridruejo, Daniela Schiodi, Eduardo Fassio, Hugo Tanno, Norberto Tamagnone, Martin Tagle, Pedro Montes, I Medina-Caliz, Mercedes Robles-Díaz, Aida Ortega-Alonso, Miren García-Cortes, Hao Niu, Ismael Alvarez-Alvarez, Rocío Romero-Flores, M Isabel Lucena, Raul J Andrade   +22 more
doaj   +1 more source

Antitumour activity of 1,1-bis-(pyrimidine-2,4-diono-1-il)-2-bromo-2-chloroethylenes substituted molecular complexes and bacterial lectin

Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2015
The aim of research. One of the most successful directions of new antitumour preparations finding is the investigation of antimetabolites of pyrimidin’s and purin’s change which forwards as preformed compounds at the link of biosynthetic processes (DNA ...
E. V. Welchinska
doaj   +1 more source

EFFICACY OF PROBIOTICS IN PREVENTING CHEMOTHERAPY-INDUCED DIARRHEA IN GASTROINTESTINAL CANCER PATIENTS [PDF]

Arquivos de Gastroenterologia
Background: Chemotherapy-induced diarrhea is a common and distressing side effect experienced by patients undergoing cancer treatment, particularly those with gastrointestinal cancer. It can lead to significant health complications, including dehydration,
Gabriel Caio DE SOUZA, Humberto Bezerra de Araujo FILHO, Cleyton Zanardo DE OLIVEIRA, Ana Paula Ribeiro PAIOTTI, Nora Manoukian FORONES   +4 more
doaj   +1 more source

Anti-mutagenic and Pro-apoptotic Effects of Apigenin on Human Chronic Lymphocytic Leukemia Cells [PDF]

Acta Medica Iranica, 2010
Diet can play a vital role in cancer prevention. Nowadays the scientists are looking for food materials which can potentially prevent the cancer occurrence.
Mehrdad Hashemi, Mehdi Nouri Long, Maliheh Entezari, Shohreh Nafisi, Hossein Nowroozii   +4 more
doaj   +1 more source

Long‐Term Outcomes of Patients With Relapsed/Refractory Neuroblastoma Treated on ANBL1221: A Report From the Children's Oncology Group

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Results of COG ANBL1221 changed treatment paradigms for patients with relapsed/refractory neuroblastoma. Chemoimmunotherapy with irinotecan/temozolomide/dinutuximab is now used as both bridge therapy following suboptimal response to induction and as treatment in first relapse.
Elizabeth Sokol, Arlene Naranjo, Lulu Chen, Rajen Mody, Steven G. DuBois, Rochelle Bagatell, Navin Pinto   +6 more
wiley   +1 more source

Bioequivalence study between two formulations of 10mg lenalidomide capsules in healthy male subjects under fasting conditions

Brazilian Journal of Oncology, 2023
OBJECTIVE: To evaluate pharmaceutical bioequivalence between two formulations of 10mg lenalidomide capsules in healthy male subjects under fasting conditions.
Carlos Sverdloff, Vinicius Marcondes Rezende, Ligia de Cassia Val, Nelly Cristina Castro, Maria Elena Cedano Limón, Mohammad H. Badii, Sreekanth Kakarla, Murali Pendela, Lygia Bonnato   +8 more
doaj   +1 more source

Reciprocal control of viral infection and phosphoinositide dynamics

FEBS Letters, EarlyView.
Phosphoinositides, although scarce, regulate key cellular processes, including membrane dynamics and signaling. Viruses exploit these lipids to support their entry, replication, assembly, and egress. The central role of phosphoinositides in infection highlights phosphoinositide metabolism as a promising antiviral target.
Marie Déborah Bancilhon, Bruno Mesmin
wiley   +1 more source